Functions and biosynthesis of plasmalogens in health and disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1636, Issue 2-3, 2004, Pages 219-231

  Brites, Pedro ^a   Waterham, Hans R ^a   Wanders, Ronald J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Metabolic disorder; Peroxisome; Plasmalogen

Indexed keywords

ANTIOXIDANT; ENZYME; LIPID; PHOSPHOLIPID; PLASMALOGEN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BIOSYNTHESIS; BLOOD CELL; CATALYSIS; CELLULAR DISTRIBUTION; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; DEGRADATION; DISEASE COURSE; DISEASE SEVERITY; DOWN SYNDROME; DYNAMICS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; GENERAL ASPECTS OF DISEASE; GENETIC ANALYSIS; HEALTH; HUMAN; LIPID ANALYSIS; LIPID STORAGE; MORPHOLOGY; NEURONAL CEROID LIPOFUSCINOSIS; NIEMANN PICK DISEASE; PATHOGENESIS; PEROXISOME; PRIORITY JOURNAL; PROTEIN FUNCTION; REACTION ANALYSIS; RETINITIS PIGMENTOSA; REVIEW; SARCOLEMMA; SEQUENCE ANALYSIS; SYMPTOM; ZELLWEGER SYNDROME;

HUMANS; HYDROLYSIS; PLASMALOGENS; SUBCELLULAR FRACTIONS;

EID: 2942633430     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.12.010     Document Type: Review

References (138)

1. Hajra A.K. Dihydroxyacetone phosphate acyltransferase. Biochim. Biophys. Acta. 1348:1997;27-34
2. Brown A.J., Snyder F. Alkyldihydroxyacetone-P synthase. Solubilization, partial purification, new assay method, and evidence for a ping-pong mechanism. J. Biol. Chem. 257:1982;8835-8839
3. Singh H., Beckman K., Poulos A. Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkyl-dihydroxyacetone phosphate synthase in rat liver. J. Lipid Res. 34:1993;467-477
4. Hayashi H., Sato A. Fatty alcohol synthesis accompanied with chain elongation in liver peroxisomes. Biochim. Biophys. Acta. 1346:1997;38-44
5. Ghosh M.K., Hajra A.K. Subcellular distribution and properties of acyl/alkyl dihydroxyacetone phosphate reductase in rodent livers. Arch. Biochem. Biophys. 245:1986;523-530
6. Datta S.C., Ghosh M.K., Hajra A.K. Purification and properties of acyl/alkyl dihydroxyacetone-phosphate reductase from guinea pig liver peroxisomes. J. Biol. Chem. 265:1990;8268-8274
7. Rock C.O., Snyder F. A short-chain acyl-CoA: 1-alkyl-2-acyl-sn-glycerol acyltrasnferase from a microsomal fraction of the rabbit Harderian gland. Biochim. Biophys. Acta. 388:1975;226-230
8. Fleming P.J., Hajra A.K. 1-Alkyl-sn-glycero-3-phosphate: acyl-CoA acyltransferase in rat brain microsomes. J. Biol. Chem. 252:1977;1663-1672
9. Mancini A., Del Rosso F., Roberti R., Orvietani P., Coletti L., Binaglia L. Purification of ethanolaminephosphotransferase from bovine liver microsomes. Biochim. Biophys. Acta. 1437:1999;80-92
10. Lee T.C., Qian C.G., Snyder F. Biosynthesis of choline plasmalogens in neonatal rat myocytes. Arch. Biochem. Biophys. 286:1991;498-503
11. Gitsham A.M., Burdett K., Tappia P.S., Connock M.J., Johnson P. Enzymes of plasmalogen biosynthesis in microperoxisomes of guinea-pig intestinal mucosa. Biochem. Soc. Trans. 17:1989;1074-1075
12. Hardeman D., van den Bosch H. Topography of ether phospholipid biosynthesis. Biochim. Biophys. Acta. 1006:1989;1-8
13. Hajra A.K., Bishop J.E. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann. N.Y. Acad. Sci. 386:1982;170-182
14. Infante J.P. Biosynthesis of acyl-specific glycerophospholipids in mammalian tissues. Postulation of new pathways. FEBS Lett. 170:1984;1-14
15. Synder F., Lee T.-C., Wykle R.L. Ether-linked glycerolipids and their bioactive species: enzymes and metabolic regulation. Martonosi A.N. The Enzymes of Biological Membranes. 1985;1-58 Plenum, New York
16. Steinberg S.J., Wang S.J., McGuinness M.C., Watkins P.A. Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein. Mol. Genet. Metab. 68:1999;32-42
17. Smith B.T., Sengupta T.K., Singh I. Intraperoxisomal localization of very-long-chain fatty acyl-CoA synthetase: implication in X- adrenoleukodystrophy. Exp. Cell Res. 254:2000;309-320
18. Visser W.F., van Roermund C.W., Waterham H.R., Wanders R.J. Identification of human PMP34 as a peroxisomal ATP transporter. Biochem. Biophys. Res. Commun. 299:2002;494-497
19. Kohl L., Drmota T., Thi C.D., Callens M., Van Beeumen J., Opperdoes F.R., Michels P.A. Cloning and characterization of the NAD-linked glycerol-3-phosphate dehydrogenases of Trypanosoma brucei brucei and Leishmania mexicana mexicana and expression of the trypanosome enzyme in Escherichia coli. Mol. Biochem. Parasitol. 76:1996;159-173
20. Hajra A.K., Larkins L.K., Das A.K., Hemati N., Erickson R.L., MacDougald O.A. Induction of the peroxisomal glycerolipid-synthesizing enzymes during differentiation of 3T3-L1 adipocytes. Role in triacylglycerol synthesis. J. Biol. Chem. 275:2000;9441-9446
21. Biermann J., Just W.W., Wanders R.J., Van Den Bosch H. Alkyl-dihydroxyacetone phosphate synthase and dihydroxyacetone phosphate acyltransferase form a protein complex in peroxisomes. Eur. J. Biochem. 261:1999;492-499
22. Biermann J., Schoonderwoerd K., Hom M.L., Luthjens L.H., Van den Bosch H. The native molecular size of alkyl-dihydroxyacetonephosphate synthase and dihydroxyacetonephosphate acyltransferase. Biochim. Biophys. Acta. 1393:1998;137-142
23. Subramani S., Koller A., Snyder W.B. Import of peroxisomal matrix and membrane proteins. Ann. Rev. Biochem. 69:2000;399-418
24. Ofman R., Hettema E.H., Hogenhout E.M., Caruso U., Muijsers A.O., Wanders R.J. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum. Mol. Genet. 7:1998;847-853
25. de Vet E.C.J.M., van den Broek B.T.E., van den Bosch H. Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2. Biochim. Biophys. Acta. 1346:1997;25-29
26. Ofman R., Lajmir S., Wanders R.J. Etherphospholipid biosynthesis and dihydroxyactetone-phosphate acyltransferase: resolution of the genomic organization of the human gnpat gene and its use in the identification of novel mutations. Biochem. Biophys. Res. Commun. 281:2001;754-760
27. de Vet E.C.J.M., Ijlst L., Oostheim W., Wanders R.J.A., van Den Bosch H. Alkyl-dihydroxyacetonephosphate synthase. Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J. Biol. Chem. 273:1998;10296-10301
28. de Vet E.C., Ijlst L., Oostheim W., Dekker C., Moser H.W., van Den Bosch H., Wanders R.J. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J. Lipid Res. 40:1999;1998-2003
29. Post J.A., Verkleij A.J., Roelofsen B., Op de Kamp J.A. Plasmalogen content and distribution in the sarcolemma of cultured neonatal rat myocytes. FEBS Lett. 240:1988;78-82
30. Kirschner D.A., Ganser A.L. Myelin labeled with mercuric chloride. Asymmetric localization of phosphatidylethanolamine plasmalogen. J. Mol. Biol. 157:1982;635-658
31. Fellmann P., Herve P., Devaux P.F. Transmembrane distribution and translocation of spin-labeled plasmalogens in human red blood cells. Chem. Phys. Lipids. 66:1993;225-230
32. Pike L.J., Han X., Chung K.N., Gross R.W. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 41:2002;2075-2088
33. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1:2000;31-39
34. Rintala J., Seemann R., Chandrasekaran K., Rosenberg T.A., Chang L., Contreras M.A., et al. 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. NeuroReport. 10:1999;3887-3890
35. Yang H.C., Farooqui A.A., Horrocks L.A. Characterization of plasmalogen-selective phospholipase A2 from bovine brain. Adv. Exp. Med. Biol. 416:1996;309-313
36. Yang H.C., Farooqui A.A., Horrocks L.A. Plasmalogen-selective phospholipase A2 and its role in signal transduction. J. Lipid Mediators Cell Signal. 14:1996;9-13
37. Hazen S.L., Stuppy R.J., Gross R.W. Purification and characterization of canine myocardial cytosolic phospholipase A2. A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids. J. Biol. Chem. 265:1990;10622-10630
38. Ford D.A., Hazen S.L., Saffitz J.E., Gross R.W. The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. J. Clin. Invest. 88:1991;331-335
39. Portilla D., Dai G. Purification of a novel calcium-independent phospholipase A2 from rabbit kidney. J. Biol. Chem. 271:1996;15451-15457
40. Portilla D., Crew M.D., Grant D., Serrero G., Bates L.M., Dai G., Sasner M., Cheng J., Buonanno A. cDNA cloning and expression of a novel family of enzymes with calcium-independent phospholipase A2 and lysophospholipase activities. J. Am. Soc. Nephrol. 9:1998;1178-1186
41. Gross R.W., Ramanadham S., Kruszka K.K., Han X., Turk J. Rat and human pancreatic islet cells contain a calcium ion independent phospholipase A2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and is specifically localized to islet beta-cells. Biochemistry. 32:1993;327-336
42. Latorre E., Collado M.P., Fernandez I., Aragones M.D., Catalan R.E. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. Eur. J. Biochem. 270:2003;36-46
43. Schonefeld M., Noble S., Bertorello A.M., Mandel L.J., Creer M.H., Portilla D. Hypoxia-induced amphiphiles inhibit renal Na+, K(+)-ATPase. Kidney Int. 49:1996;1289-1296
44. McHowat J., Liu S., Creer M.H. Selective hydrolysis of plasmalogen phospholipids by Ca2+-independent PLA2 in hypoxic ventricular myocytes. Am. J. Physiol. 274:1998;C1727-C1737
45. Jaffe E.R., Gottfried E.L. Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes. J. Clin. Invest. 47:1968;1375-1388
46. Arthur G., Page L., Mock T., Choy P.C. The catabolism of plasmenylcholine in the guinea pig heart. Biochem. J. 236:1986;475-480
47. Jurkowitz-Alexander M.S., Horrocks L.A. Lysoplasmalogenase: solubilization and partial purification from liver microsomes. Methods Enzymol. 197:1991;483-490
48. Jurkowitz-Alexander M., Ebata H., Mills J.S., Murphy E.J., Horrocks L.A. Solubilization, purification and characterization of lysoplasmalogen alkenylhydrolase (lysoplasmalogenase) from rat liver microsomes. Biochim. Biophys. Acta. 1002:1989;203-212
49. Gunawan J., Debuch H. Lysoplasmalogenase - a microsomal enzyme from rat brain. J. Neurochem. 39:1982;693-699
50. Williams S.D., Ford D.A. Activation of myocardial cAMP-dependent protein kinase by lysoplasmenylcholine. FEBS Lett. 420:1997;33-38
51. Mangold H.K., Weber N. Biosynthesis and biotransformations of ether lipids. Lipids. 22:1987;789-799
52. Reiss D., Beyer K., Engelmann B. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J. 323(Pt 3):1997;807-814
53. Zoeller R.A., Lake A.C., Nagan N., Gaposchkin D.P., Legner M.A., Lieberthal W. Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem. J. 338(Pt 3):1999;769-776
54. Sindelar P.J., Guan Z., Dallner G., Ernster L. The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26:1999;318-324
55. Lukacova N., Chavko M., Halat G. Effect of stobadine on lipid peroxidation and phospholipids in rabbit spinal cord after ischaemia. Neuropharmacology. 32:1993;235-241
56. Zoeller R.A., Grazia T.J., LaCamera P., Park J., Gaposchkin D.P., Farber H.W. Increasing plasmalogen levels protects human endothelial cells during hypoxia. Am. J. Physiol., Heart Circ. Physiol. 283:2002;H671-H679
57. Dudda A., Spiteller G., Kobelt F. Lipid oxidation products in ischemic porcine heart tissue. Chem. Phys. Lipids. 82:1996;39-51
58. Hahnel D., Huber T., Kurze V., Beyer K., Engelmann B. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem. J. 340(Pt 2):1999;377-383
59. Hahnel D., Thiery J., Brosche T., Engelmann B. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. Arterioscler. Thromb. Vasc. Biol. 19:1999;2431-2438
60. Gutteridge J.M. Lipid peroxidatin and antioxidants as biomarkers of tissue damage. Clin. Biochem. 41:1995;1819-1928
61. Hermetter A., Rainer B., Ivessa E., Kalb E., Loidl J., Roscher A., Paltauf F. Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: a fluorescence anisotropy study. Biochim. Biophys. Acta. 978:1989;151-157
62. Glaser P.E., Gross R.W. Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion. Biochemistry. 33:1994;5805-5812
63. Lohner K. Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? Chem. Phys. Lipids. 81:1996;167-184
64. Lohner K., Balgavy P., Hermetter A., Paltauf F., Laggner P. Stabilization of non-bilayer structures by the etherlipid ethanolamine plasmalogen. Biochim. Biophys. Acta. 1061:1991;132-140
65. Paltauf F. Ether lipids in biomembranes. Chem. Phys. Lipids. 74:1994;101-139
66. Rudiger M., Kolleck I., Putz G., Wauer R.R., Stevens P., Rustow B. Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. Am. J. Physiol. 274:1998;L143-L148
67. Tolle A., Meier W., Rudiger M., Hofmann K.P., Rustow B. Effect of cholesterol and surfactant protein B on the viscosity of phospholipid mixtures. Chem. Phys. Lipids. 114:2002;159-168
68. Favrelere S., Stadelmann-Ingrand S., Huguet F., De Javel D., Piriou A., Tallineau C., Durand G. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging. 21:2000;653-660
69. Rustow B., Kolleck I., Guthmann F., Haupt R., Kunze D., Stevens P. Synthesis and secretion of plasmalogens by type-II pneumocytes. Biochem. J. 302(Pt 3):1994;665-668
70. Rana F.R., Harwood J.S., Mautone A.J., Dluhy R.A. Identification of phosphocholine plasmalogen as a lipid component in mammalian pulmonary surfactant using high-resolution 31P NMR spectroscopy. Biochemistry. 32:1993;27-31
71. Han X.L., Gross R.W. Alterations in membrane dynamics elicited by amphiphilic compounds are augmented in plasmenylcholine bilayers. Biochim. Biophys. Acta. 1069:1991;37-45
72. Mandel H., Sharf R., Berant M., Wanders R.J., Vreken P., Aviram M. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells. Biochem. Biophys. Res. Commun. 250:1998;369-373
73. Munn N.J., Arnio E., Liu D., Zoeller R.A., Liscum L. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. J. Lipid Res. 44:2003;182-192
74. Blank M.L., Smith Z.L., Lee Y.J., Snyder F. Effects of eicosapentaenoic and docosahexaenoic acid supplements on phospholipid composition and plasmalogen biosynthesis in P388D1 cells. Arch. Biochem. Biophys. 269:1989;603-611
75. Ford D.A., Gross R.W. Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. Proc. Natl. Acad. Sci. U. S. A. 86:1989;3479-3483
76. Gaposchkin D.P., Zoeller R.A. Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. J. Lipid Res. 40:1999;495-503
77. Mitchell D.C., Niu S.-L., Litman B.J. Optimization of receptor-G protein coupling by bilayer lipid composition I: kinetics of rhodopsin-transducin binding. J. Biol. Chem. 276:2001;42801-42806
78. Niu S.-L., Mitchell D.C., Litman B.J. Optimization of receptor-G protein coupling by bilayer lipid composition II: formation of metarhodopsin II-transducin complex. J. Biol. Chem. 276:2001;42807-42811
79. Farooqui A.A., Yang H.C., Horrocks L.A. Plasmalogens, phospholipases A2 and signal transduction. Brain Res. Brain Res. Rev. 21:1995;152-161
80. Di Marzo V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukot. Essent. Fat. Acids. 53:1995;239-254
81. Mitchell D.C., Niu S.L., Litman B.J. DHA-rich phospholipids optimize G-Protein-coupled signaling. J. Pediatr. 143:2003;S80-S86
82. Schrakamp G., Schutgens R.B., Wanders R.J., Heymans H.S., Tager J.M., Van den Bosch H. The cerebro-hepato-renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts. Biochim. Biophys. Acta. 833:1985;170-174
83. Gootjes J., Mooijer P.A., Dekker C., Barth P.G., Poll-The B.T., Waterham H.R., Wanders R.J. Biochemical markers predicting survival in peroxisome biogenesis disorders. Neurology. 59:2002;1746-1749
84. Weller S., Gould S.J., Valle D. Peroxisome biogenesis disorders. Annu. Rev. Genomics. Hum. Genet. 4:2003;165-211
85. Perichon R., Moser A.B., Wallace W.C., Cunningham S.C., Roth G.S., Moser H.W. Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. Biochem. Biophys. Res. Commun. 248:1998;57-61
86. Styger R., Wiesmann U.N., Honegger U.E. Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. Biochim. Biophys. Acta. 1585:2002;39-43
87. Brul S., Wiemer E.A., Westerveld A., Strijland A., Wanders R.J., Schram A.W., Heymans H.S., Schutgens R.B., VandenBosch H., Tager J.M. Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) syndrome and related disorders. Biochem. Biophys. Res. Commun. 152:1988;1083-1089
88. Roscher A.A., Hoefler S., Hoefler G., Paschke E., Paltauf F., Moser A., Moser H. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis - a complementation study involving cell lines from 19 patients. Pediatr. Res. 26:1989;67-72
89. Gould S.J., Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet. 16:2000;340-345
90. Gray R.G., Green A., Chapman S., McKeown C., Schutgens R.B., Wanders R.J. Rhizomelic chondrodysplasia punctata - a new clinical variant. J. Inherit. Metab. Dis. 15:1992;931-932
91. Heikoop J.C., Wanders R.J., Strijland A., Purvis R., Schutgens R.B., Tager J.M. Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata - a complementation study. Hum. Genet. 89:1992;439-444
92. Motley A.M., Brites P., Gerez L., Hogenhout E., Haasjes J., Benne R., Tabak H.F., Wanders R.J., Waterham H.R. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am. J. Hum. Genet. 70:2002;612-624
93. Nuoffer J.M., Pfammatter J.P., Spahr A., Toplak H., Wanders R.J., Schutgens R.B., Wiesmann U.N. Chondrodysplasia punctata with a mild clinical course. J. Inherit. Metab. Dis. 17:1994;60-66
94. van den Brink D.M., Brites P., Haasjes J., Wierzbicki A.S., Mitchell J., LambertHamill M., de Belleroche J., Jansen G.A., Waterham H.R., Wanders R.J. Identification of PEX7 as the second gene involved in Refsum disease. Am. J. Hum. Genet. 72:2003;471-477
95. Braverman N., Chen L., Lin P., Obie C., Steel G., Douglas P., Chakraborty P.K., Clarke J.T., Boneh A., Moser A., Moser H., Valle D. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Human Mutat. 20:2002;284-297
96. Hoefler G., Hoefler S., Watkins P.A., Chen W.W., Moser A., Baldwin V., McGillivary B., Charrow J., Friedman J.M., Rutledge L., et al. Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J. Pediatr. 112:1988;726-733
97. Schutgens R.B., Bouman I.W., Nijenhuis A.A., Wanders R.J., Frumau M.E. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Clin. Chem. 39:1993;1632-1637
98. Wells T.R., Landing B.H., Bostwick F.H. Studies of vertebral coronal cleft in rhizomelic chondrodysplasia punctata. Pediatr. Pathol. 12:1992;593-600
99. Poulos A., Sheffield L., Sharp P., Sherwood G., Johnson D., Beckman K., Fellenberg A.J., Wraith J.E., Chow C.W., Usher S., et al. Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. J. Pediatr. 113:1988;685-690
100. Spranger J.W., Opitz J.M., Bidder U. Heterogeneity of chondrodysplasia punctata. Humangenetik. 11:1971;190-212
101. Powers J.M., Moser H.W. Peroxisomal Disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol. 8:1998;101-120
102. Powers J.M., Kenjarski T.P., Moser A.B., Moser H.W. Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells. Acta Neuropathol. (Berl.). 98:1999;129-134
103. Sztriha L.S., Nork M.P., Abdulrazzaq Y.M., al-Gazali L.I., Bakalinova D.B. Abnormal myelination in peroxisomal isolated dihydroxyacetonephosphate acyltransferase deficiency. Pediatr. Neurol. 16:1997;232-236
104. Sztriha L., Al-Gazali L.I., Wanders R.J., Ofman R., Nork M., Lestringant G.G. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev. Med. Child Neurol. 42:2000;492-495
105. Viola A., Confort-Gouny S., Ranjeva J.P., Chabrol B., Raybaud C., Vintila F., Cozzone P.J. MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. AJNR Am. J. Neuroradiol. 23:2002;480-483
106. Alkan A., Kutlu R., Yakinci C., Sigirci A., Aslan M., Sarac K. Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. Magn. Reson. Imaging. 21:2003;77-80
107. Thai T.P., Rodemer C., Jauch A., Hunziker A., Moser A., Gorgas K., Just W.W. Impaired membrane traffic in defective ether lipid biosynthesis. Hum. Mol. Genet. 10:2001;127-136
108. Ginsberg L., Rafique S., Xuereb J.H., Rapoport S.I., Gershfeld N.L. Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res. 698:1995;223-226
109. Ginsberg L., Xuereb J.H., Gershfeld N.L. Membrane instability, plasmalogen content, and Alzheimer's disease. J. Neurochem. 70:1998;2533-2538
110. Han X., Holtzman D.M., McKeel D.W. Jr. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77:2001;1168-1180
111. Farooqui A.A., Horrocks L.A. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist. 7:2001;232-245
112. Ehehalt R., Keller P., Haass C., Thiele C., Simons K. Amyloidogenic processing of the Alzheimer b-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160:2003;113-123
113. Pentchev P.G., Comly M.E., Kruth H.S., Vanier M.T., Wenger D.A., Patel S., Brady R.O. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl. Acad. Sci. U. S. A. 82:1985;8247-8251
114. Roff C.F., Goldin E., Comly M.E., Blanchette-Mackie J., Cooney A., Brady R.O., Pentchev P.G. Niemann-Pick type-C disease: deficient intracellular transport of exogenously derived cholesterol. Am. J. Med. Genet. 42:1992;593-598
115. Schedin S., Sindelar P.J., Pentchev P., Brunk U., Dallner G. Peroxisomal impairment in Niemann-Pick type C disease. J. Biol. Chem. 272:1997;6245-6251
116. Nagan N., Zoeller R.A. Plasmalogens: biosynthesis and functions. Prog. Lipid Res. 40:2001;199-229
117. Murphy E.J., Schapiro M.B., Rapoport S.I., Shetty H.U. Phospholipid composition and levels are altered in Down syndrome brain. Brain Res. 867:2000;9-18
118. Goebel H.H., Sharp J.D. The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol. 8:1998;151-162
119. Kohlschutter A., Schade B., Blomer B., Hubner C. Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis (JNCL). J. Inherit. Metab. Dis. 16:1993;299-304
120. Granier L.A., Langley K., Leray C., Sarlieve L.L. Phospholipid composition in late infantile neuronal ceroid lipofuscinosis. Eur. J. Clin. Investig. 30:2000;1011-1017
121. Wisniewski K.E., Kida E., Connell F., Elleder M., Eviatar L., Konkol R.J. New subform of the late infantile form of neuronal ceroid lipofuscinosis. Neuropediatrics. 24:1993;155-163
122. Bennett M.J., Poirier S.F., Chern L., Gayton A.R., Hosking G.P., Le N.-A., Majumdar S., Korchak H.M. Juvenile Neuronal ceroid-lipofuscinosis: characterization of the Dyslipoproteinaemia and demonstration of membrane phospholipid and phospholipid-dependent signal transduction abnormalities in cultured skin fibroblasts. J. Inherit. Metab. Dis. 16:1993;308-311
123. Wisniewski K.E., Gordon-Krajcer W., Kida E. Abnormal processing of carboxy-terminal fragment of beta precursor protein (beta PP) in neuronal ceroid-lipofuscinosis (NCL) cases. J. Inherit. Metab. Dis. 16:1993;312-316
124. Rivolta C., Sharon D., DeAngelis M.M., Dryja T.P. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum. Mol. Genet. 11:2002;1219-1227
125. Hims M.M., Diager S.P., Inglehearn C.F. Retinitis pigmentosa: genes, proteins and prospects. Dev. Ophthalmol. 37:2003;109-125
126. Gartner S., Henkind P. Pathology of retinitis pigmentosa. Ophthalmology. 89:1982;1425-1432
127. Pacione L.R., Szego M.J., Ikeda S., Nishina P.M., McInnes R.R. Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. Annu. Rev. Neurosci. 26:2003;657-700
128. Gong J., Rosner B., Rees D.G., Berson E.L., Weigel-DiFranco C.A., Schaefer E.J. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest. Ophthalmol. Visual Sci. 33:1992;2596-2602
129. Schaefer E.J., Robins S.J., Patton G.M., Sandberg M.A., Weigel-DiFranco C.A., Rosner B., Berson E.L. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J. Lipid Res. 36:1995;1427-1433
130. Hoffman D.R., DeMar J.C., Heird W.C., Birch D.G., Anderson R.E. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J. Lipid Res. 42:2001;1395-1401
131. Rotstein N.P., Politi L.E., German O.L., Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest. Ophthalmol. Visual Sci. 44:2003;2252-2259
132. Wilson G.N., Holmes R.G., Custer J., Lipkowitz J.L., Stover J., Datta N., Hajra A. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. Am. J. Med. Genet. 24:1986;69-82
133. Baes M., Gressens P., Baumgart E., Carmeliet P., Casteels M., Fransen M., Evrard P., Fahimi D., Declercq P.E., Collen D., van Veldhoven P.P., Mannaerts G.P. A mouse model for Zellweger syndrome. Nat. Genet. 17:1997;49-57
134. Faust P.L., Hatten M.E. Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J. Cell Biol. 139:1997;1293-1305
135. Maxwell M., Bjorkman J., Nguyen T., Sharp P., Finnie J., Paterson C., Tonks I., Paton B.C., Kay G.F., Crane D.I. Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype. Mol. Cell. Biol. 23:2003;5947-5957
136. Brites P., Motley A.M., Gressens P., Mooyer P.A., Ploegaert I., Everts V., Evrard P., Carmeliet P., Dewerchin M., Schoonjans L., Duran M., Waterham H.R., Wanders R.J., Baes M. Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. Hum. Mol. Genet. 12:2003;2255-2267
137. Rodemer C., Thai T.P., Brugger B., Kaercher T., Werner H., Nave K.A., Wieland F., Gorgas K., Just W.W. Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum. Mol. Genet. 12:2003;1881-1895
138. Lee T.C. Biosynthesis and possible biological functions of plasmalogens. Biochim. Biophys. Acta. 1394:1998;129-145